About 250 Mg Abiraterone Acetate Tablets IP
Introducing our Select 250 Mg Abiraterone Acetate Tablets IP, an exclusive prescription medicine designed for the monumental task of treating metastatic castration-resistant prostate cancer (mCRPC). Each first-string tablet contains Abiraterone Acetate 250 mg, crafted to the finest Indian Pharmacopoeia standards for trusted efficacy. Presented in a special 1x120-tablet bottle, this potent antiandrogen promises compliance and safety. Not for use in women or children; consult your physician for guidance. Experience our commitment to premium cancer management with meticulous quality and professional support from a leading distributor and exporter in India.
Key Applications and Usage Recommendations
250 Mg Abiraterone Acetate Tablets IP serve as an advanced therapeutic choice for patients diagnosed with metastatic castration-resistant prostate cancer (mCRPC). As a prescription-only, oral-use specialist medication, it is intended exclusively for adult male patients. Administered under strict physician supervision, the tablets are to be taken on an empty stomach to maximize absorption. This select treatment modality demonstrates exceptional efficacy in advanced prostate cancer management, providing hope and support for eligible individuals.
Secure Packaging and Swift Delivery Logistics
Each bottle, containing 120 film-coated tablets, is encased in robust, moisture-resistant packaging to preserve the product's integrity. With an assured shelf life of 24-36 months, our supply chain enables quick dispatch and reliable delivery to wholesalers, pharmacies, and healthcare institutions. Leveraging sophisticated logistics and secure shipping practices, we ensure safe arrival and timely accessibility, offering peace of mind for both providers and patients across India and export markets.
FAQ's of 250 Mg Abiraterone Acetate Tablets IP:
Q: How should 250 Mg Abiraterone Acetate Tablets IP be administered?
A: These tablets are to be taken orally on an empty stomach, as directed by your physician. It's important to follow the prescribed dosing schedule for optimum effectiveness.
Q: What benefits does this medication offer patients with advanced prostate cancer?
A: 250 Mg Abiraterone Acetate Tablets IP provide a potent, clinically proven antiandrogen therapy, helping to slow disease progression and manage metastatic castration-resistant prostate cancer (mCRPC) in eligible male patients.
Q: When should patients avoid using this medicine?
A: This medication is contraindicated in women and children. Prior consultation with a healthcare professional is essential to determine individual suitability and manage potential risks.
Q: What is the process for storing these tablets safely?
A: Store the tablets in their original container below 30C, protected from moisture and direct light, to maintain their efficacy and shelf life.
Q: Where can healthcare providers source the product securely?
A: Our 250 Mg Abiraterone Acetate Tablets IP can be supplied to clinics, hospitals, and pharmacies through authorized distributors, exporters, and suppliers across India, with secure shipping and reliable logistics support.
Q: What potential side effects should be monitored during treatment?
A: Patients should be aware of possible side effects, including hypertension, hypokalemia, edema, and hepatotoxicity. Regular monitoring by a physician is recommended to manage these risks effectively.